Dyfyniad APA

Wakabayashi, Y., Masuda, T., Fujitaka, K., Nakashima, T., Okumoto, J., Shimoji, K., . . . Hattori, N. (2020). Clinical significance of BIM deletion polymorphism in chemoradiotherapy for non‐small cell lung cancer. Cancer Sci.

Dyfyniad Arddull Chicago

Wakabayashi, Yu, et al. "Clinical Significance of BIM Deletion Polymorphism in Chemoradiotherapy for Non‐small Cell Lung Cancer." Cancer Sci 2020.

Dyfyniad MLA

Wakabayashi, Yu, et al. "Clinical Significance of BIM Deletion Polymorphism in Chemoradiotherapy for Non‐small Cell Lung Cancer." Cancer Sci 2020.

Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.